MBMR Biolabs
New York
About MBMR Biolabs
MBMR Biolabs offers inverse-electron demand diels-alder cycloaddition between trans-cyclooctenes and tetrazines that is biocompatible. Their applications have been developed that utilise tetrazine cycloaddition to image and retrieve nucleic acids, proteins, glycans, lipids, and other metabolites in vitro, in cells as well as in whole organisms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $499.8K
- Last round: Grant (Mar 2012)
- Website: mbmrbiolabs.com
- Phone: +1 866 248 5556
Industries & Categories
Biotechnology, Chemical, Chemical Engineering
Canonical: https://fsome.com/organization/mbmr-biolabs-3204003 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.